The Obesity Society Statement on Safety Concerns Related to Compounded GLP-1 Rockville, MD - March 12, 2026 - Jacqueline M. Stephens, PhD, FTOS, President of The Obesity Society (TOS), the nation’s leading scientific organization dedicated to advancing the understanding, prevention, and treatment of obesity, released the following statement on reports that an impurity has been [...]
Rockville, MD — March 5 — Leading obesity experts have released new guidance confirming that obesity medications are safe, effective, and appropriate for long-term use. These findings will give millions of Americans living with obesity greater clarity and confidence in their treatment options. The Obesity Society [...]
Rockville, MD — With obesity rates rising and millions of Americans still unable to access comprehensive, evidence-based treatment, The Obesity Society (TOS) is using Obesity Care Week 2026 to spotlight obesity as a serious, chronic disease and to emphasize the importance of expanding access to care. Obesity Care Week (March 2-6) is a coordinated [...]
Jacqueline M. Stephens, PhD, FTOS, president of The Obesity Society (TOS), the leading scientific organization dedicated to advancing the understanding, prevention, and treatment of obesity, released the following statement on the Centers for Medicare & Medicaid Services’ (CMS) launch of the BALANCE Model. “The BALANCE Model represents meaningful progress toward modernizing obesity care across [...]
Rockville, MD - January 7, 2026 - Jacqueline M. Stephens, PhD, FTOS, President of The Obesity Society (TOS), the nation’s leading scientific organization dedicated to advancing the understanding, prevention, and treatment of obesity, released the following statement regarding the recently issued updated Dietary Guidelines and their implications for obesity care. “The Obesity Society is concerned [...]
Atlanta, GA – November 6, 2025 – Marc-André Cornier, MD, FTOS, President of The Obesity Society (TOS), the nation’s leading scientific organization dedicated to advancing the understanding, prevention, and treatment of obesity, released the following statement on the White House’s agreement with major pharmaceutical companies to lower costs and expand access to FDA-approved obesity [...]
Media invited to attend virtually or in person for the latest on GLP-1 therapies, food policy, and obesity treatment reform ATLANTA — October 14, 2025 — ObesityWeek® 2025, hosted by The Obesity Society (TOS), returns to Atlanta from November 4–7, offering journalists a front-row seat, virtually or in person, to the most important conversations [...]
Atlanta – Who decides what we eat, how we pay for care, and whether obesity is treated as a disease or a personal choice? At ObesityWeek® 2025, hosted by The Obesity Society (TOS) from November 4–7 in Atlanta, leading scientists, policymakers, and advocates will go head-to-head on the most divisive questions shaping obesity treatment [...]
Atlanta – GLP-1 therapies are reshaping clinical practice, health policy, economics, and patient expectations. At ObesityWeek® 2025, hosted by The Obesity Society (TOS) in Atlanta from November 4–7, media will have the chance to move beyond the hype and gain direct access to the science, debates, and future direction of obesity treatment through a [...]
Atlanta – The Obesity Society (TOS) is pleased to invite credentialed media to attend ObesityWeek® 2025, the world’s preeminent scientific conference on obesity research, treatment and policy. The conference will be held November 4–7, 2025, in Atlanta, Georgia, bringing together leading researchers, clinicians, policymakers and advocates from around the world. Registration is free for [...]
